You can now access the SIU 2024 B2B GU Cancers Triad proceedings, published as a supplement to the February issue of SIUJ. Review the latest updates on bladder, kidney and prostate cancers that were presented by expert faculty.
Access the proceedings from the 6th B2B GU Cancers Triad Meeting today! Content is completely open access and serves as an important resource for urologists and allied health care practitioners around the world to engage with leading GU oncology research from 2024.
The meeting proceedings cover important updates systemic therapies and sequencing, developments in surgical techniques and supporting technologies, advances in personalized care, as well as emerging results from key clinical trials.
Click the image below below to read the complete B2B meeting proceedings on SIU Academy—no login required.
